Scientific & Medical communication services
Visual Science helps biotech and pharmaceutical teams communicate complex biology and mechanisms with precision and clarity — to HCPs, KOLs, investors, patients, and caregivers.
480+
projects completed since 2007
98.3%
clients rate working with us 9 or 10/10
63
awards, incl. two from Science and NSF
28%
of our team members hold PhD/MD degrees
480+
projects completed since 2007
98.3%
clients rate working with us 9 or 10/10
63
awards, incl. two from Science and NSF
28%
of our team members hold PhD/MD degrees
480+
projects completed since 2007
98.3%
clients rate working with us 9 or 10/10
63
awards, incl. two from Science and NSF
28%
of our team members hold PhD/MD degrees
480+
projects completed since 2007
98.3%
clients rate working with us 9 or 10/10
63
awards, incl. two from Science and NSF
28%
of our team members hold PhD/MD degrees
Trusted Scientific Communications for Breakthrough Biology
We focus on a narrow set of high-science services, delivering exceptional scientific rigor, clarity, and speed across programs from early pipeline through commercial stages. Our work spans scientific platforms and narratives, MoA/MoD animations, decks, clinical and educational content, and advanced digital formats — all grounded in scientific rigor and built to scale.
7 medical animation types and 20 subtypes
MoA/MoD Animation Services
We offer 7 scientifically rigorous MoA and MoD animation types and 20+ subtypes—the widest and most configurable option set on the market—so you can match detail, timeline, and budget to any audience and program stage. From fast pathway formats delivered in days to science-grade molecular 3D informed by advanced modeling and simulations.
Our modular framework lets us mix and match formats, reuse validated building blocks, and scale one story into a coordinated suite—MoA, platform overviews, trial updates, congress touch panels, field tools, and chapterized interactive learning scenarios—without sacrificing accuracy or visual clarity. Every format meets the same bar: PhD/MD-led rigor, clean storytelling, and an engineering-driven production pipeline with 3x production speed.
Corporate and Medical Affairs websites and portals
Corporate and Medical Affairs Websites and Portals
We design and build corporate and Medical Affairs websites that turn complex science into clear, structured, and scalable digital experiences. From corporate story and pipeline pages to disease education and HCP resource hubs, we translate your science into high-engagement resources that are easy to navigate, build on, and maintain at the market’s lowest cost. With our approach, 98% of content update tasks can be managed by client internal teams.
We create modular design systems and reusable components optimized to integrate existing assets (MoA, visuals, data). The result is dramatically faster launches and updates, cleaner governance, and a site that stays current—supporting field teams, congress moments, and ongoing medical education.
Corporate, investor, partner and medical affairs decks
Corporate, Investor, Partner and Medical Affairs Decks
We create corporate, investor, partner, and Medical Affairs decks that translate complex biology into a clear, persuasive narrative with science-grade visuals. Beyond design, we support scientific storytelling—message architecture, scientific/medical writing, and narrative flow—so the science is accurate, compelling, and easy to follow.
For corporate/investor/partner decks, we bring our team’s Investor Relations to sharpen the corporate message and strengthen structure. For Medical Affairs decks, we apply deep MedAffairs expertise to deliver evidence-first logic and an HCP-ready tone. We also provide templates, guidelines, and a library of digital assets, enabling internal teams to extend the core materials into additional versions.
Selected Case Studies
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Mechanism of Action of the ENT-01 Drug
3D animation illustrating the mechanism of action of a Parkinson’s disease drug
UNI-494 Drug: Mechanism of Action
3D animation illustrating mitochondrial damage and dysfunction in kidney disease
UBX1325 MoA in Diabetic Macular Edema
Animation explaining the MoA of UBX1325 in diabetic macular edema
Animating Chemogenetics Platform
3D animation of a chemogenetics platform for targeted cell therapies
Dual AAV vectors: 3D MoA animation
3D animation explaining dual AAV vector mechanism for large gene delivery
Bridge RNAs: mechanism of action
Scientifically accurate 3D animation of Bridge RNA mechanism of action
CRISPR-Cas Mechanism of Action
High-end 3D animation explaining CRISPR-Cas gene-editing mechanisms
Virus-Based Immunotherapy Platform Animations
3D animations explaining virus-based immunotherapy platform MoA
Laterally spreading AAV.SPR vector: 3D MoA animation
Animation of the laterally spreading AAV.SPR vector for enhanced gene delivery
KRAS pathway and Tri-complex KRAS-RMC-CYPA
2 scientific animations for Science Magazine media kit for Revolution Medicines
LINE-1 reverse transcriptase animation
High-end 3D animation for Harvard University and Rome Therapeutics
Accurate 3D model and animation of HIV
Award-winning atomic resolution model of the HIV viral particle
Animating Condensate Modifying Drugs
3D explainer animation about condensate biology and drug modification (c-mods)
MoA in Age-related Macular Degeneration
3D animation explaining AMD and its effects on the macula
MoA of Quantitative Amplicon Sequencing
3D MoA animation of quantitative amplicon sequencing
MoA Animation about pHLIP Targeted Peptides
3D MOA animation explaining the pHLIP peptide-based targeted delivery platform
Modified IL-2-based cancer drug: 3D MoA
3D animation illustrating Interleukin-2 driven cancer immunotherapy mechanisms
3D Animation for a Drug Discovery Platform
Visualizing a drug-hunting discovery platform
Mechanisms of Technology and Device Animations
3D animations showing mechanisms of scientific technologies and devices
11 Educational Animations for the ACS
Series of 3D scientific animations for the American Chemical Society
Metatide Peptide 3D MoA Animation
Animation showing how Metatide peptide-drug conjugates target tumor tissue
MoA of a Wound Debridement Platform
3D animation showing the mechanism of action of a tissue repair platform
Animating DNA Manufacturing Platform
3D explainer animation of a large-scale DNA manufacturing platform
RAS(ON) Inhibitors MoA Animation
Animating the mechanism of action of RAS-ON inhibitors targeting active RAS proteins
Searching for Target Sites on DNA
3D animation visualizing how proteins locate specific target sites on DNA
Jasper Tx's corporate presentation
Corporate presentation summarizing clinical programs and strategy
Animating Early-Stage Gene Therapy Technology
3D MoA of cancer-specific genetic activation for tumor detection and therapy
Visualizing IL-18-based Immune Therapy
MoA animation explaining Fuse Bio’s IL-18–based technology
Animating Macrocyclic Peptide Discovery Platform
3D animation of a bacterial platform
Synthetic Super-Enhancers MoA Animation
3D MoA animation explaining the Odysseus gene therapy platform for investors
Plixorafenib Redefines BRAF Mutation Targeting
Concise MoA animation of plixorafenib for investor and industry communication
Cell-Based Therapy for Bladder Cancer MoA
MoA animation explaining the mechanism of TARA-002 for investors
Atopic Dermatitis Antibody Treatment
3D MoA animation of Apogee’s antibodies (APG777 & APG990) for atopic dermatitis
Antibody-Drug Conjugate Targeting TGF-β
3D MoA animation of Bicara’s dual-action treatment targeting solid tumors
SPYRE Tx's corporate presentation
Presentation translating SPYRE’s scientific and strategic narrative
Apogee Tx's corporate presentation
Corporate presentation about scientific and strategic narrative
Frequently asked questions
What makes Visual Science different from other medical animation companies?
What makes Visual Science different from other medical animation companies?
What makes Visual Science different from other medical animation companies?
What makes Visual Science different from other medical animation companies?
How long does a typical 1 to 1.5 minute MoA or MoD animation take from brief to delivery, and why is Visual Science able to deliver up to 3 times faster than other agencies?
How long does a typical 1 to 1.5 minute MoA or MoD animation take from brief to delivery, and why is Visual Science able to deliver up to 3 times faster than other agencies?
How long does a typical 1 to 1.5 minute MoA or MoD animation take from brief to delivery, and why is Visual Science able to deliver up to 3 times faster than other agencies?
How long does a typical 1 to 1.5 minute MoA or MoD animation take from brief to delivery, and why is Visual Science able to deliver up to 3 times faster than other agencies?
How much internal time is typically required from client teams to review a 1–2 minute MoA or MoD animation?
How much internal time is typically required from client teams to review a 1–2 minute MoA or MoD animation?
How much internal time is typically required from client teams to review a 1–2 minute MoA or MoD animation?
How much internal time is typically required from client teams to review a 1–2 minute MoA or MoD animation?
We already work with a healthcare communications agency. When does it make sense to add Visual Science?
We already work with a healthcare communications agency. When does it make sense to add Visual Science?
We already work with a healthcare communications agency. When does it make sense to add Visual Science?
We already work with a healthcare communications agency. When does it make sense to add Visual Science?
How does Visual Science ensure and review scientific accuracy in each project?
How does Visual Science ensure and review scientific accuracy in each project?
How does Visual Science ensure and review scientific accuracy in each project?
How does Visual Science ensure and review scientific accuracy in each project?
Can Visual Science support urgent projects, including last-minute requests?
Can Visual Science support urgent projects, including last-minute requests?
Can Visual Science support urgent projects, including last-minute requests?
Can Visual Science support urgent projects, including last-minute requests?
What types of projects and budget ranges are a good fit for Visual Science, and how do you stay competitive on cost while maintaining scientific depth, deliver 2-3 times faster than other medical animation companies. How is that possible?
What types of projects and budget ranges are a good fit for Visual Science, and how do you stay competitive on cost while maintaining scientific depth, deliver 2-3 times faster than other medical animation companies. How is that possible?
What types of projects and budget ranges are a good fit for Visual Science, and how do you stay competitive on cost while maintaining scientific depth, deliver 2-3 times faster than other medical animation companies. How is that possible?
What types of projects and budget ranges are a good fit for Visual Science, and how do you stay competitive on cost while maintaining scientific depth, deliver 2-3 times faster than other medical animation companies. How is that possible?
How does Visual Science handle MLR and compliance requirements?
How does Visual Science handle MLR and compliance requirements?
How does Visual Science handle MLR and compliance requirements?
How does Visual Science handle MLR and compliance requirements?
Can Visual Science work with companies that have AORs or single-agency policies?
Can Visual Science work with companies that have AORs or single-agency policies?
Can Visual Science work with companies that have AORs or single-agency policies?
Can Visual Science work with companies that have AORs or single-agency policies?
Who owns the IP and usage rights for the animations and visuals Visual Science creates, and can assets be reused across Medical Affairs, investor, and commercial channels?
Who owns the IP and usage rights for the animations and visuals Visual Science creates, and can assets be reused across Medical Affairs, investor, and commercial channels?
Who owns the IP and usage rights for the animations and visuals Visual Science creates, and can assets be reused across Medical Affairs, investor, and commercial channels?
Who owns the IP and usage rights for the animations and visuals Visual Science creates, and can assets be reused across Medical Affairs, investor, and commercial channels?
Contact us
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
Contact us
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
10/10
“
We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”
CEO, Atsena Therapeutics
10/10
“
The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”
Program Manager, American Chemical Society
10/10
“
Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”
CEO, Apton Biosystems
9/10
“
Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”
VP, Head of Communications, Scorpion Tx
7/10
“
The structural biology models from Visual Science are stunning! Visual Science implemented our guidelines into beautiful scientific imagery for our website and scientific slide decks.”
Science Content Lead, Dewpoint Tx
9/10
“
I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”
Vice President, R&D, Unicycive Tx
10/10
“
We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”
CSO, Enterin
10/10
“
The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”
CEO, UNITY Biotechnology
10/10
“
Beautiful work that is detailed and thoughtful. Great final output.”
Sr. Comms & IR Associate, Candel Tx
10/10
“
We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.”
President & CEO, ROME Tx
10/10
“
Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”
VP, Corp Dev, Revolution Medicines
Contact us
Contact us
Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.
We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.
© 2026, Visual Science. All rights reserved.
Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.
We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.
© 2026, Visual Science. All rights reserved.
Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.
We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.
© 2026, Visual Science. All rights reserved.
Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.
We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.
© 2026, Visual Science. All rights reserved.
